🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Cohort of Patients With Left Ventricular Thrombus: Management and Outcomes in the Direct Oral Anticoagulants Era

Recruitingn/aAges 18 Years - anyAllInsel Gruppe AG, University Hospital Bern
NCT05028777 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The investigators' primary objective is to assess whether a difference in the occurrence of bleeding events exist between patients with LVT treated with DOACs as compared to those treated with VKAs.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients at least 18 years old at enrolment * With a LVT identified at echocardiography, MRI or CT between January 1st, 2013 and July 31st, 2020 * Treated at least once at the Inselspital or in another site of the Insel Gruppe * Able to provide a written informed consent Exclusion Criteria: * Documented refusal
💊

What it tests

  • Not listed
📍

Where

1 site
Department of Cardiology, University Hospital Bern
Bern, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy